IL17A and COVID-19: Significantly higher expression of IFN-γ (<i>p</i> = 0.0153), IL-6 (<i>p</i> < 0.0001), IL-10 (<i>p</i> < 0.0001), IL-17A (<i>p</i> = 0.0310), and TNF-α (<i>p</i> = 0.0034) was observed in COVID-19 patients compared to uninfected participants.